Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 10/20 | 0.55 |
| ▸ | CYP11B1 | P15538 | 9/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.55 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.51 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | HPGDS | O60760 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20009904 | 0.99 | CYP11B2 (0.54) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20009960 | 0.97 | CYP11B2 (0.58) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20010223 | 0.96 | CYP11B2 (0.57) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20010179 | 0.96 | CYP11B2 (0.56) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20010183 | 0.95 | CYP11B2 (0.56) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20010274 | 0.93 | CYP11B2 (0.60) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20010180 | 0.92 | CYP11B2 (0.59) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20010070 | 0.91 | CYP11B1 (0.50) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20010133 | 0.90 | CYP2A6 (0.51) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL20010042 | 0.90 | CYP2A6 (0.49) | CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210320261-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
| US-11081648-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | LG DISPLAY CO., LTD. (KR) | 2021-08-03 | — | — | US | disclosed |
| US-10468605-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | LG DISPLAY CO., LTD. (KR) | 2019-11-05 | — | — | US | disclosed |
| US-20180090686-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
| US-20180090686-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180090686-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD1, OCIAD2, AOX1 | CYP11B2 1249/4885CYP11B1 1561/4885CYP19A1 1250/4885 |
| US-20210320261-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD1, OCIAD2, AOX1 | CYP11B2 1112/4885CYP11B1 1434/4885CYP19A1 1268/4885 |
| US-10468605-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | OCIAD1, OCIAD2, AOX1 | CYP11B2 1249/4885CYP11B1 1561/4885CYP19A1 1250/4885 |
| US-11081648-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | OCIAD1, OCIAD2, AOX1 | CYP11B2 1249/4885CYP11B1 1561/4885CYP19A1 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.